Risk reduction and tolerability of fluvastatin in patients with the metabolic syndrome: a pooled analysis of thirty clinical trials
… The 5 secondary prevention clinical end point studies from the larger group of all studies … risk, including those with metS or type 2 diabetes and existing CVD. 2 Thus, many patients with …..... Read More